A TIP FROM FDA LED TO SEC S SUIT
Selected Abstract
A TIP FROM FDA LED TO SEC'S SUIT AGAINST BIOPURE
The FDA dropped the dime. According to a government official, a tip from the Food and Drug Administration led to a lawsuit that security regulators filed last month against Biopure Corp., the Cambridge artificial-blood developer. In the suit, filed Sept. 14 in US District Court in Boston, the ... October 10, 2005; The Boston Globe
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
A TIP FROM FDA LED TO SEC'S SUIT AGAINST BIOPURE
|
